HomeAll ContractsContract
DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC
Total Committed
$686M
Product or Service Description
Biomedical Advanced Development R&D
Effective Date
May 24, 2020
Funding Department
OFFICE OF ACQ MGMT POLICY
Type
Firm fixed price
Solicitation Procedure
Subject to multiple award fair opportunity
Extent Competed
Full and open competition

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION March 23, 2021 Supplemental Agreement For Work Within Scope $22,815,455
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC UPDATE CONTRACTOR'S KEYS PERSONNEL Jan. 21, 2021 Other Administrative Action $0
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC TO REDUCE THE AMOUNT OF MANUFACTURING CAPACITY RESERVED Nov. 17, 2020 Change Order -$10,000,000
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC PROVIDE FOR CONSIDERATION / OFFSET IN COST FOR DOD PERSONNEL AGREEMENT Oct. 7, 2020 Supplemental Agreement For Work Within Scope $0
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC UPDATE FAR CLAUSES IN TASK ORDER Sept. 18, 2020 Supplemental Agreement For Work Within Scope $0
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC UPGRADE TASK ORDER TO PRIORITY RATING - DEFENSE PRIORITIES AND ALLOCATIONS SYSTEM Aug. 21, 2020 Other Administrative Action $0
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC UPGRADE TASK ORDER TO A DEFENSE PRIORITIES ALLOCATIONS SYSTEM RATING TASK ORDER Aug. 20, 2020 Other Administrative Action $0
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC TO EXPAND THE PUBLIC-PRIVATE PARTNERSHIP WITH EMERGENT TO RESERVE THE CAPACITIES AND CAPABILITIES AT CONTRACTOR?S BAYVIEW CIADM FACILITY. July 23, 2020 $30,000,000
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION May 24, 2020 $628,250,000
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC April 2, 2020 $14,531,801
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page